[go: up one dir, main page]

ES2180977T3 - Un derivado de 1-metilcarbapenem. - Google Patents

Un derivado de 1-metilcarbapenem.

Info

Publication number
ES2180977T3
ES2180977T3 ES97919696T ES97919696T ES2180977T3 ES 2180977 T3 ES2180977 T3 ES 2180977T3 ES 97919696 T ES97919696 T ES 97919696T ES 97919696 T ES97919696 T ES 97919696T ES 2180977 T3 ES2180977 T3 ES 2180977T3
Authority
ES
Spain
Prior art keywords
group
hydrogen atom
derivative
rent
renting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97919696T
Other languages
English (en)
Inventor
Isao Kawamoto
Munetsugu Morimoto
Katsuya Ishikawa
Katsuhiko Kojima
Yasuo Shimoji
Satoshi Ohya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2180977T3 publication Critical patent/ES2180977T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

[CONSTITUCION] UN COMPUESTO DE 1 - METILCARBAPENEN REPRESENTADO POR LA SIGUIENTE FORMULA: [EN LA QUE R 1 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO INFERIOR, R 2 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO INFERIOR, R3 REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO INF ERIOR, UN GRUPO ALQUILO INFERIOR QUE TIENE UN SUSTITUYENTE, UN GRUPO CICLOALQUILO O UN GRUPO DE FORMULA - C (=NR)R 4 (EN LA QUE R 4 REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO INFERIOR O UN GRUPO AMINO)]; O UNA SAL O DERIVADO FARMACOLOGICAMENTE ACEPTABLE DE LOS MISMOS. [VENTAJAS] LOS COMPUESTOS DE 1- METILCARBAPENEN DE LA PRESENTE INVENCION MUESTRAN EXCELENTE ACTIVIDAD ANTIBACTERIANA Y SON PUES EFECTIVOS COMO PREVENTIVOS O REMEDIO DE INFECCIONES.
ES97919696T 1996-04-26 1997-04-25 Un derivado de 1-metilcarbapenem. Expired - Lifetime ES2180977T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10736496 1996-04-26

Publications (1)

Publication Number Publication Date
ES2180977T3 true ES2180977T3 (es) 2003-02-16

Family

ID=14457217

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97919696T Expired - Lifetime ES2180977T3 (es) 1996-04-26 1997-04-25 Un derivado de 1-metilcarbapenem.

Country Status (17)

Country Link
US (1) US5977097A (es)
EP (1) EP0900797B1 (es)
KR (1) KR20000064997A (es)
CN (1) CN1093861C (es)
AT (1) ATE222588T1 (es)
AU (1) AU710881B2 (es)
CA (1) CA2252723A1 (es)
CZ (1) CZ342098A3 (es)
DE (1) DE69714841T2 (es)
DK (1) DK0900797T3 (es)
ES (1) ES2180977T3 (es)
HU (1) HUP9902149A3 (es)
NO (1) NO312900B1 (es)
NZ (1) NZ332453A (es)
PT (1) PT900797E (es)
RU (1) RU2162088C2 (es)
WO (1) WO1997041123A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882728B1 (en) * 1995-12-21 2002-09-04 Sankyo Company Limited 1-methylcarbapenem derivatives
WO2000034282A1 (en) * 1998-12-07 2000-06-15 Sankyo Company, Limited 1-methylcarbapenem derivatives
AU748949B2 (en) * 1999-06-23 2002-06-13 Merck & Co., Inc. Integrin receptor antagonists
HU230700B1 (hu) * 2001-09-26 2017-09-28 Merck Sharp & Dohme Corp Eljárás karbapenemvegyületek előállítására
CA2531578C (en) * 2003-12-09 2008-10-07 Choongwae Pharm. Co. A new process for preparation of imipenem
JPWO2008026527A1 (ja) * 2006-08-28 2010-01-21 株式会社カネカ ３−シアノピロリジン誘導体およびその塩の製造方法
CN101357917B (zh) * 2007-06-22 2011-03-23 山东轩竹医药科技有限公司 含有甲酰肼基的碳青霉烯化合物
CN101367809B (zh) * 2007-06-28 2011-04-27 山东轩竹医药科技有限公司 含有巯基吡咯烷甲酰肼的培南衍生物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
EP0182213B1 (en) * 1984-11-08 1990-09-26 Sumitomo Pharmaceuticals Company, Limited Carbapenem compounds and production thereof
JP2752143B2 (ja) * 1988-04-01 1998-05-18 三共株式会社 カルバペネム誘導体
FI91258C (fi) * 1988-04-01 1994-06-10 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten 2-(heterosyklyylitio)karbapeneemijohdannaisten valmistamiseksi
JPH023687A (ja) * 1988-06-22 1990-01-09 Sankyo Co Ltd １−メチルカルバペネム誘導体
JPH04211083A (ja) * 1990-02-23 1992-08-03 Sankyo Co Ltd カルバペネム−３−カルボン酸誘導体
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
AU651887B2 (en) * 1991-06-04 1994-08-04 Sankyo Company Limited 1-methylcarbapenem derivatives, their preparation and their use as antibiotics
HU218676B (hu) * 1992-03-11 2000-10-28 Sankyo Co. Ltd. Antimikrobiális karbapenemszármazékok, ilyen vegyületeket tartalmazó gyógyászati készítmények és eljárás ezek előállítására
JP3411589B2 (ja) * 1992-05-11 2003-06-03 第一製薬株式会社 カルバペネム誘導体
JP3344662B2 (ja) * 1992-09-14 2002-11-11 三共株式会社 カルバペネム−３−カルボン酸誘導体
JPH06199860A (ja) * 1992-09-16 1994-07-19 Sankyo Co Ltd カルバペネム誘導体
JPH07228570A (ja) * 1993-12-22 1995-08-29 Sankyo Co Ltd ４−メルカプトピロリジン誘導体
JP3199300B2 (ja) * 1994-05-09 2001-08-13 三共株式会社 １−メチルカルバペネム誘導体
JPH0848667A (ja) * 1994-06-03 1996-02-20 Sankyo Co Ltd ４−メルカプトピロリジン誘導体

Also Published As

Publication number Publication date
AU2407697A (en) 1997-11-19
NZ332453A (en) 2000-09-29
EP0900797B1 (en) 2002-08-21
CZ342098A3 (cs) 1999-02-17
CN1093861C (zh) 2002-11-06
ATE222588T1 (de) 2002-09-15
DK0900797T3 (da) 2002-09-09
AU710881B2 (en) 1999-09-30
NO312900B1 (no) 2002-07-15
NO984948D0 (no) 1998-10-23
KR20000064997A (ko) 2000-11-06
WO1997041123A1 (en) 1997-11-06
US5977097A (en) 1999-11-02
CN1223655A (zh) 1999-07-21
EP0900797A1 (en) 1999-03-10
CA2252723A1 (en) 1997-11-06
HUP9902149A2 (hu) 1999-10-28
NO984948L (no) 1998-12-21
DE69714841T2 (de) 2003-05-28
HK1018260A1 (en) 1999-12-17
EP0900797A4 (en) 2000-07-19
RU2162088C2 (ru) 2001-01-20
DE69714841D1 (de) 2002-09-26
HUP9902149A3 (en) 2002-01-28
PT900797E (pt) 2002-11-29

Similar Documents

Publication Publication Date Title
GT199700016A (es) Derivados de triazol utiles en terapia
ES2172585T3 (es) Derivado de benzoimidazol.
EP0731106A4 (en) Novel peptide derivative
ECSP045104A (es) Ligandos de los receptores de los cannabinoides
BR9714377B1 (pt) compostos derivados de 3-tiocarbamoilpirazol, seus processos de preparaÇço, uso, assim como pesticidas contendo referidos compostos.
ES2179071T3 (es) Agentes vasodilatadores perifericos que comprenden como principio activo derivados de la piperidina 4-amino n-acilada.
DE69716925D1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
ATE227293T1 (de) 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
DE69411271D1 (de) N-alkylthiopolyaminderivate als radioprotektive mittel
ES2156933T3 (es) Derivados triciclicos de benzazepina y benzotiazepina.
ES2180977T3 (es) Un derivado de 1-metilcarbapenem.
DE69634961D1 (de) Neue zyklische depsipeptid pf1022 derivate
ES2181927T3 (es) Derivados de 1-metilcarbapenem.
TR200002932T2 (tr) Azabisayklik 5HT1 Alıcı liganolları
ATE277017T1 (de) 1,2-disubstituierte 1,4-dihydro-4-oxochinolin- verbindungen
BG105710A (en) 5ht1 antagonists for antidepressant therapy
ES2158290T3 (es) Derivados de tiazolidinona opticamente activos.
AR012688A1 (es) Proceso para la preparacion de un compuesto derivado de (-)-trans-1-bencil- 3-hidroximetil-4-(4-fluorofenil)piperidina y paroxetina preparada a partirde dicho compuesto
ES2170804T3 (es) Derivados de dihidro-2,3-benzodiazepina.
ES2191852T3 (es) Procedimiento para producir derivados de depsipeptido y sus nuevos intermedios.
DE69624365D1 (de) Penizillaminamid-derivate
ES2195313T3 (es) Derivados de imino-aza-antraciclinona para el tratamiento de la amiloidosis.
PT1301504E (pt) Agentes bifuncionais possuindo actividade anti-oxidante e antiarritmica
DK1328275T3 (da) Substituerede 4,5-dihydro-1,2,4-triazin-3-oner, 1,2,4-triazin-3-oner og deres anvendelse som fungicider og insekticider
DE69600714D1 (de) Antiallergische Zusammensetzung enthaltend eine Phosphorsäurediester-Verbindung